Squarepoint
NSPR icon

Squarepoint’s InspireMD NSPR Stock Holding History

Squarepoint’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15
Closed -$12K – 1950
2018
Q1 		$12K Buy
+15
New +$51.7K ﹤0.01% 1631

Other funds holding NSPR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Squarepoint's NSPR Position: Q2 2018 in Review

Squarepoint sold out of InspireMD (NSPR) in Q2 2018, closing a stake of 15 shares — an estimated $12K sold.

Squarepoint first reported a position in NSPR in Q1 2018 and held it in 1 quarter. The position peaked at $12K in Q1 2018. 10 funds tracked by Wall St. Rank hold NSPR as of Q2 2018.

  • Squarepoint reported no remaining InspireMD position as of Q2 2018 after selling out during the quarter.
  • Squarepoint sold 15 InspireMD shares in Q2 2018, an estimated $12K.
  • Squarepoint first reported a position in InspireMD in Q1 2018 and held it in 1 quarter.
  • Squarepoint's InspireMD position peaked at $12K in Q1 2018.
  • 10 funds tracked by Wall St. Rank held InspireMD as of Q2 2018.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.